Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial

Haddad, 2008, Recent advances in head and neck cancer, N Engl J Med, 359, 1143, 10.1056/NEJMra0707975 Forastiere, 2003, Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer, N Engl J Med, 349, 2091, 10.1056/NEJMoa031317 Ang, 2005, Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14, J Clin Oncol, 23, 3008, 10.1200/JCO.2005.12.060 Adelstein, 2003, An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer, J Clin Oncol, 21, 92, 10.1200/JCO.2003.01.008 Pignon, 2000, Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data, Lancet, 355, 949, 10.1016/S0140-6736(00)90011-4 Pignon, 2009, Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients, Radiother Oncol, 92, 4, 10.1016/j.radonc.2009.04.014 Bonner, 2006, Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck, N Engl J Med, 354, 567, 10.1056/NEJMoa053422 Ang, 2011, A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC), Proc Am Soc Clin Oncol, 29 Posner, 2007, Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer, N Engl J Med, 357, 1705, 10.1056/NEJMoa070956 Vermorken, 2007, Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer, N Engl J Med, 357, 1695, 10.1056/NEJMoa071028 Pointreau, 2009, Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation, J Natl Cancer Inst, 101, 498, 10.1093/jnci/djp007 Bernier, 2004, Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer, N Engl J Med, 350, 1945, 10.1056/NEJMoa032641 Cooper, 2004, Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck, N Engl J Med, 350, 1937, 10.1056/NEJMoa032646 Forastiere, 2012, Long term results of Intergroup RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer, J Clin Oncol Paccagnella, 2010, Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study, Ann Oncol, 21, 1515, 10.1093/annonc/mdp573 Hitt, 2009, Proc Am Soc Clin Oncol, 27 Cohen, 2012, DeCIDE: A phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN), Proc Am Soc Clin Oncol, 30 Tishler, 2006, Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck, Int J Radiat Oncol Biol Phys, 65, 1036, 10.1016/j.ijrobp.2006.02.010 Ang, 2010, Human papillomavirus and survival of patients with oropharyngeal cancer, N Engl J Med, 363, 24, 10.1056/NEJMoa0912217 Gillison, 2000, Evidence for a causal association between human papillomavirus and a subset of head and neck cancers, J Natl Cancer Inst, 92, 709, 10.1093/jnci/92.9.709 Mork, 2001, Human Papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck, N Engl J Med, 344, 1125, 10.1056/NEJM200104123441503 Rischin, 2010, Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial, J Clin Oncol, 28, 4142, 10.1200/JCO.2010.29.2904 Posner, 2011, Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial, Ann Oncol, 22, 1071, 10.1093/annonc/mdr006